The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Targeted next generation sequencing (NGS) of matched primary tumor, metastasis, circulating tumor cells (CTCs), and cell-free DNA (cfDNA) in a patient with advanced prostate cancer (PC).
 
Cory Michael Hugen
No Relationships to Disclose
 
Pamela Ward
No Relationships to Disclose
 
Jonas Petterson
No Relationships to Disclose
 
Louis Dubeau
No Relationships to Disclose
 
Paul W. Dempsey
Employment - Cynvenio Biosystems
Stock and Other Ownership Interests - Cynvenio Biosystems
Patents, Royalties, Other Intellectual Property - Cynvenio Biosystems
 
Brian Robin Hu
No Relationships to Disclose
 
Tong Xu
No Relationships to Disclose
 
David I. Quinn
Honoraria - Astellas Pharma; Bayer; Bristol-Myers Squibb; Dendreon; Fresenius Kabi; Genentech/Roche; Janssen Oncology; Medivation; Novartis; Pfizer
Consulting or Advisory Role - Algeta/Bayer; Astellas Pharma; Bristol-Myers Squibb; Dendreon; Genentech/Roche; Janssen Oncology; Medivation; Novartis; Pfizer
Research Funding - Genentech/Roche (Inst); GlaxoSmithKline (Inst); Millennium (Inst); Sanofi (Inst)
Expert Testimony - Medivation; Teva
 
Amir Goldkorn
No Relationships to Disclose